Assignee
XOMA CORP
US·140 granted patents·7 pending applications·10,648 citations·filing 1982–2016
Top patents by PatentIndex Score
147 records- 0199US5500362AChimeric antibody with specificity to human B cell surface antigenXOMA CORP·Filed 1991·Granted Mar 19, 1996·2.8k cites·9 claims
- 0298US5721108AChimeric antibody with specificity to human B cell surface antigenXOMA CORP·Filed 1995·Granted Feb 24, 1998·269 cites·25 claims
- 0398US5698417AModular assembly of antibody genes, antibodies prepared thereby and useXOMA CORP·Filed 1995·Granted Dec 16, 1997·272 cites·17 claims
- 0498US5693493AModular assembly of antibody genes, antibodies prepared thereby and useXOMA CORP·Filed 1995·Granted Dec 2, 1997·272 cites·9 claims
- 0598US5677180AChimeric antibody with specificity to human B cell surface antigenXOMA CORP·Filed 1995·Granted Oct 14, 1997·316 cites·12 claims
- 0698US5618920AModular assembly of antibody genes, antibodies prepared thereby and useXOMA CORP·Filed 1994·Granted Apr 8, 1997·562 cites·45 claims
- 0798US5576195AVectors with pectate lyase signal sequenceXOMA CORP·Filed 1994·Granted Nov 19, 1996·270 cites·35 claims
- 0897US5869619AModified antibody variable domainsXOMA CORP·Filed 1993·Granted Feb 9, 1999·462 cites·17 claims
- 0997US5698435AModular assembly of antibody genes, antibodies prepared thereby and useXOMA CORP·Filed 1995·Granted Dec 16, 1997·207 cites·20 claims
- 1097US5595898AModular assembly of antibody genes, antibodies prepared thereby and useXOMA CORP·Filed 1994·Granted Jan 21, 1997·184 cites·4 claims
- 1197US5576184AProduction of chimeric mouse-human antibodies with specificity to human tumor antigensXOMA CORP·Filed 1994·Granted Nov 19, 1996·292 cites·4 claims
- 1296US5846818APectate lyase signal sequenceXOMA CORP·Filed 1995·Granted Dec 8, 1998·182 cites·21 claims
- 1396US5821123AModified antibody variable domainsXOMA CORP·Filed 1995·Granted Oct 13, 1998·146 cites·15 claims
- 1496US5766886AModified antibody variable domainsXOMA CORP·Filed 1992·Granted Jun 16, 1998·1.3k cites·23 claims
- 1595US4489710AComposition and method for transplantation therapyXOMA CORP·Filed 1982·Granted Dec 25, 1984·141 cites·6 claims
- 1694US5770196AModified antibody variable domains and therapeutic uses thereofXOMA CORP·Filed 1995·Granted Jun 23, 1998·122 cites·18 claims
- 1791US5744580AImmunotoxins comprising ribosome-inactivating proteinsXOMA CORP·Filed 1995·Granted Apr 28, 1998·57 cites·36 claims
- 1891US5348942ATherapeutic uses of bactericidal/permeability increasing protein productsXOMA CORP·Filed 1993·Granted Sep 20, 1994·100 cites·2 claims
- 1990US5420019AStable bactericidal/permeability-increasing protein muteinsXOMA CORP·Filed 1993·Granted May 30, 1995·59 cites·19 claims
- 2090US5411941AHeterodimeric osteogenic factorXOMA CORP·Filed 1993·Granted May 2, 1995·72 cites·6 claims
- 2190US5093475AHindered linking agents derived from 2-iminothiolanes and methodsXOMA CORP·Filed 1989·Granted Mar 3, 1992·30 cites·48 claims
- 2289US5523288AMethod of treating gram-negative bacterial infection by administration of bactericidal/permeability-increasing (BPI) protein product and antibioticXOMA CORP·Filed 1994·Granted Jun 4, 1996·77 cites·37 claims
- 2389US5028530AAraB promoters and method of producing polypeptides, including cecropins, by microbiological techniquesXOMA CORP·Filed 1990·Granted Jul 2, 1991·90 cites·14 claims
- 2489US4925922APotentiation of cytotoxic conjugatesXOMA CORP·Filed 1989·Granted May 15, 1990·135 cites·8 claims
- 2588US6255284B1Pharmaceutical compositionXOMA CORP·Filed 2000·Granted Jul 3, 2001·26 cites·8 claims
- 2688US5578572AAnti-gram-positive bacterial methods and materialsXOMA CORP·Filed 1995·Granted Nov 26, 1996·62 cites·13 claims
- 2787US4590071AHuman melanoma specific immunotoxinsXOMA CORP·Filed 1984·Granted May 20, 1986·79 cites·20 claims
- 2886US5621083AImmunotoxins comprising ribosome-inactivating proteinsXOMA CORP·Filed 1995·Granted Apr 15, 1997·44 cites·10 claims
- 2985US5484705AMethod for quantifying lipopolysaccharide binding proteinXOMA CORP·Filed 1994·Granted Jan 16, 1996·50 cites·2 claims
- 3085US5447913ATherapeutic uses of bactericidal/permeability-increasing protein dimer productsXOMA CORP·Filed 1994·Granted Sep 5, 1995·41 cites·12 claims
- 3185US4916213ARibosomal inhibiting protein-immunoglobulin conjugates with specificity for tumor cell surface antigens, and mixtures thereofXOMA CORP·Filed 1988·Granted Apr 10, 1990·103 cites·28 claims
- 3284US6146631AImmunotoxins comprising ribosome-inactivating proteinsXOMA CORP·Filed 1997·Granted Nov 14, 2000·30 cites·54 claims
- 3384US5837491APolynucleotides encoding gelonin sequencesXOMA CORP·Filed 1994·Granted Nov 17, 1998·55 cites·20 claims
- 3484US5733872ABiologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereofXOMA CORP·Filed 1994·Granted Mar 31, 1998·33 cites·45 claims
- 3584US5488034APharmaceutical composition comprising BPI proteinsXOMA CORP·Filed 1994·Granted Jan 30, 1996·54 cites·6 claims
- 3683US5508263AHeterodimeric osteogenic factorXOMA CORP·Filed 1994·Granted Apr 16, 1996·40 cites·2 claims
- 3783US5416202AMaterials comprising and methods of preparation and use for ribosome-inactivating proteinsXOMA CORP·Filed 1992·Granted May 16, 1995·59 cites·23 claims
- 3882US6599880B1Bactericidal/permeability-increasing protein (BPI) deletion analogsXOMA CORP·Filed 2000·Granted Jul 29, 2003·5 cites·39 claims
- 3982US6107280AAntithrombotic materials and methodsXOMA CORP·Filed 1999·Granted Aug 22, 2000·40 cites·6 claims
- 4082US5783561AAnti-gram-positive bacterial methods and materialsXOMA CORP·Filed 1996·Granted Jul 21, 1998·44 cites·24 claims
- 4182US4698420AAntibody hybrid molecules and process for their preparationXOMA CORP·Filed 1985·Granted Oct 6, 1987·52 cites·16 claims
- 4280US6599881B1Antithrombotic materials and methodsXOMA CORP·Filed 2000·Granted Jul 29, 2003·9 cites·6 claims
- 4379US5639727ATherapeutic uses of bactericidal/permeability increasing protein productsXOMA CORP·Filed 1995·Granted Jun 17, 1997·34 cites·5 claims
- 4479US4664913AMethod for treating plasma for transfusionXOMA CORP·Filed 1984·Granted May 12, 1987·56 cites·8 claims
- 4578US5858974AAnti-fungal peptidesXOMA CORP·Filed 1996·Granted Jan 12, 1999·33 cites·15 claims
- 4677US6268345B1Bactericidal/permeability-increasing protein (BPI) compositionsXOMA CORP·Filed 2000·Granted Jul 31, 2001·3 cites·2 claims
- 4777US5756699AImmunotoxins comprising ribosome-inactivating proteinsXOMA CORP·Filed 1995·Granted May 26, 1998·18 cites·53 claims
- 4877US5439807AMethods for the preparation of endotoxin-binding proteinsXOMA CORP·Filed 1993·Granted Aug 8, 1995·42 cites·6 claims
- 4977US4970303ALinking agents and methodsXOMA CORP·Filed 1988·Granted Nov 13, 1990·12 cites·64 claims
- 5076US5851802AMethods for recombinant microbial production of fusion proteins and BPI-derived peptidesXOMA CORP·Filed 1996·Granted Dec 22, 1998·23 cites·15 claims
Showing the top 50 of 147 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when XOMA CORP files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →